NRx Pharmaceuticals, Inc. (NRXP)
NASDAQ: NRXP · Real-Time Price · USD
2.680
+0.040 (1.52%)
At close: Jun 2, 2025, 4:00 PM
2.720
+0.040 (1.49%)
After-hours: Jun 2, 2025, 7:51 PM EDT

NRx Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Selling, General & Admin
12.213.5114.2227.3174.9411.44
Upgrade
Research & Development
5.266.213.3717.0320.2610.63
Upgrade
Other Operating Expenses
-----0.77-10.16
Upgrade
Operating Expenses
17.4519.727.5944.3494.4311.9
Upgrade
Operating Income
-17.45-19.7-27.59-44.34-94.43-11.9
Upgrade
Interest Expense
--0.23-0.12--0.02-0.06
Upgrade
Interest & Investment Income
0.020.040.490.25--
Upgrade
Other Non Operating Income (Expenses)
-4.48-3.780.020.261.69-0.03
Upgrade
EBT Excluding Unusual Items
-21.91-23.67-27.19-43.83-92.76-11.98
Upgrade
Other Unusual Items
-2.2-1.45-2.964.08-0.31-39.79
Upgrade
Pretax Income
-24.11-25.13-30.15-39.75-93.06-51.78
Upgrade
Net Income
-24.11-25.13-30.15-39.75-93.06-51.78
Upgrade
Preferred Dividends & Other Adjustments
--0.01---
Upgrade
Net Income to Common
-24.11-25.13-30.16-39.75-93.06-51.78
Upgrade
Shares Outstanding (Basic)
13118753
Upgrade
Shares Outstanding (Diluted)
13118753
Upgrade
Shares Change (YoY)
54.22%40.50%15.20%40.17%36.90%220.58%
Upgrade
EPS (Basic)
-1.92-2.36-3.98-6.04-19.84-15.11
Upgrade
EPS (Diluted)
-1.93-2.36-3.98-6.04-74.40-15.11
Upgrade
Free Cash Flow
-10.45-10.64-21.66-39.77-37.71-2.27
Upgrade
Free Cash Flow Per Share
-0.83-1.00-2.86-6.05-8.04-0.66
Upgrade
EBITDA
-17.45-19.7-27.58-44.33-94.43-11.9
Upgrade
D&A For EBITDA
0.010.010.01000
Upgrade
EBIT
-17.45-19.7-27.59-44.34-94.43-11.9
Upgrade
Updated Mar 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q